Randomized clinical trials of transdermal nitroglycerin systems for the treatment of angina: A meta-analysis

Graham A. Colditz, Katherine T. Halvorsen, Samuel Z. Goldhaber

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

The efficacy of transdermal nitrate patches at 24 hours after application remains controversial. Definitive evaluation has been limited because most randomized trials have had relatively small sample sizes. Therefore, we performed a meta-analysis and combined the results of 17 trials. We assessed exercise test duration as the primary end point. At 3 to 4 hours after patch application, there was a 77-second increase in exercise duration (p = 0.02) for a 5 mg/24 hour dose and a 114-second increase in exercise duration (p = 0.001) for a 10 mg/24 hour dose. At 24 hours, however, the 29-second increase in exercise duration for a 10 mg/24 hour dose was not significant (p > 0.1), despite persistent decreases in systolic blood pressure, an increase in heart rate, and a "therapeutic" plasma nitroglycerin concentration. The findings indicate that the 10 mg/24 hour dose is not efficacious at 24 hours after application and support the hypothesis that nitroglycerin's effect on exercise performance is attenuated by nitrate tolerance even though hemodynamic effects and adequate blood levels persist.

Original languageEnglish
Pages (from-to)174-180
Number of pages7
JournalAmerican heart journal
Volume116
Issue number1 PART 1
DOIs
StatePublished - Jul 1988
Externally publishedYes

Fingerprint Dive into the research topics of 'Randomized clinical trials of transdermal nitroglycerin systems for the treatment of angina: A meta-analysis'. Together they form a unique fingerprint.

  • Cite this